Researchers from the Royal Marsden Hospital in London have confirmed that giving Herceptin to women with certain types of breast cancer does prolong their lives. The study, published in The Lancet, followed women for two years after treatment and found a 2.7 per cent increased survival rate compared with women not prescribed the drug.

www.thelancet.com/journals/lancet

Researchers from the Royal Marsden Hospital in London have confirmed that giving Herceptin to women with certain types of breast cancer does prolong their lives. The study, published in The Lancet, followed women for two years after treatment and found a 2.7 per cent increased survival rate compared with women not prescribed the drug.

www.thelancet.com/journals/lancet